erlotinib hydrochloride has been researched along with Hypertrichosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, KY; Kwong, B; Rahman, Z | 1 |
| Ma, PC; Medina Mendez, CA; Singh, AD | 1 |
| Braiteh, F; Johnson, FM; Kurzrock, R | 1 |
| Bachariou, A; Chasapi, V; Papadopoulos, R | 1 |
| Galvany, L; Herrera-Acosta, E; Iglesias, M; Márquez, G; Umbert, P; Vidal, I | 1 |
| Alexandrescu, DT; Dasanu, CA; Kauffman, CL | 1 |
| Gnanaraj, J; Saif, MW | 1 |
| Desai, RU; Rachakonda, LP; Saffra, NA | 1 |
| Carney, D; Forde, P; Murphy, C; O'Sullivan, C | 1 |
| Antoniou, C; Chasapi, V; Dilana, KD; Karapanagiotou, EM; Matekovits, AE; Stratigos, AJ; Syrigos, KN; Tsimboukis, S; Vergou, T | 1 |
| Fujiwara, K; Kudo, K; Matsuo, K; Mizuta, M; Sato, T; Tsushima, M; Yonei, T | 1 |
| Carser, JE; Summers, YJ | 1 |
| Basti, S; Jampol, LM; Zhang, G | 1 |
13 other study(ies) available for erlotinib hydrochloride and Hypertrichosis
| Article | Year |
|---|---|
Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Immunological; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Hemoglobins; Humans; Hypertrichosis; Intense Pulsed Light Therapy; Lasers, Dye; Male; Melanins; Middle Aged; Neoplasms | 2017 |
Acquired trichomegaly: trichomegaly secondary to erlotinib.
Topics: ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Humans; Hypertrichosis; Middle Aged; Protein Kinase Inhibitors; Quinazolines | 2014 |
Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Brain Neoplasms; Carcinoma, Bronchogenic; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Follow-Up Studies; Humans; Hypertrichosis; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Quinazolines; Risk Assessment | 2008 |
Trichomegaly induced by erlotinib.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Humans; Hypertrichosis; Lung Neoplasms; Lymphatic Metastasis; Protein Kinase Inhibitors; Quinazolines | 2008 |
A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Follow-Up Studies; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines; Risk Assessment | 2009 |
Persistent hair growth during treatment with the EGFR inhibitor erlotinib.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Neoplasms; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Hair; Hair Color; Humans; Hypertrichosis; Lung Neoplasms; Neoplasm Proteins; Paronychia; Protein Kinase Inhibitors; Quinazolines; Remission Induction | 2009 |
Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
Topics: Aged; Antineoplastic Agents; ErbB Receptors; Erlotinib Hydrochloride; Eyebrows; Eyelashes; Female; Humans; Hypertrichosis; Male; Middle Aged; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2010 |
Trichomegaly secondary to erlotinib.
Topics: Adenocarcinoma; Aged; ErbB Receptors; Erlotinib Hydrochloride; Eyebrows; Eyelashes; Humans; Hypertrichosis; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines | 2009 |
Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
Topics: Adenocarcinoma; Alopecia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines | 2011 |
Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Face; Female; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Quinazolines | 2010 |
Toxicity manifesting as cosmetic hair alterations during erlotinib treatment.
Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Erlotinib Hydrochloride; Female; Humans; Hypertrichosis; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2011 |
Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Eyelashes; Female; Follow-Up Studies; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Neoplasm Staging; Quinazolines; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
Topics: Acneiform Eruptions; Adenocarcinoma, Bronchiolo-Alveolar; Aged, 80 and over; Antineoplastic Agents; Blepharitis; Carcinoma, Small Cell; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Gefitinib; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines; Retrospective Studies | 2007 |